Past, present and development possibility of cardiooncology
Keywords:
cardiotoxity, risk factors, anthracycline, trastuzumab, immune checkpoint inhibitors, cardioprotection
Abstract
The material is devoted to a new interdisciplinary direction “Cardioncology”. Patients with oncological diseases have an increased risk of developing cardiovascular complications associated with antitumor therapy. The article describes the historical stages of the use of antitumor treatment leading to the development of cardiotoxicity, presents the current state of the problem and considers the prospects for further development. The data of russian and foreign studies in this area are presented.
Published
2022-05-16
How to Cite
Fedorets, V. N., Vershinina, S. F., Vologdina, I. V., Zhabina, R. M., Krasilnikova, L. A., Ovchinnikov, I. V., & Vasilenko, V. S. (2022). Past, present and development possibility of cardiooncology. Medicine: Theory and Practice, 7(1), 3-12. Retrieved from https://ojs3.gpmu.org/index.php/med-theory-and-practice/article/view/4061
Issue
Section
Статьи